share_log

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast

Co-Diagnostics公司宣佈2024年第三季度業績發佈日期和網絡直播
PR Newswire ·  10/26 04:01

SALT LAKE CITY, Oct. 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2024 results on Thursday, November 7, 2024, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

2024年10月25日,鹽湖城 /美通社/ -- co-diagnostics公司(納斯達克:CODX)是一傢俱有獨特專利平台用於開發分子診斷試劑盒的分子診斷公司,今日宣佈將於2024年11月7日星期四發佈其2024年第三季度業績,發佈時間將在當天納斯達克閉市後。公司還將於當天下午4:30舉行電話會議及網絡直播,與分析師和機構投資者討論其財務業績。電話會議上的管理層包括首席執行官Dwight Egan、首席財務官Brian Brown和投資者關係負責人Andrew Benson。

The conference call and webcast will be available via:

電話會議和網絡直播可通過以下方式觀看:

Webcast: ir.codiagnostics.com on the Events & Webcasts page

網絡直播:ir.codiagnostics.com 的「事件與網絡直播」頁面

Conference Call: 844-481-2661 (domestic) or 412-317-0652 (international)

電話會議:844-481-2661(國內)或412-317-0652(國際)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

如果無法參與實時網絡直播,電話會議將被錄製並稍後在公司網站上提供。

About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

關於co-diagnostics公司
Co-Diagnostics,Inc.是一家總部位於猶他州的分子診斷公司,開發,製造和銷售最先進的診斷技術。該公司的技術廣泛應用於基於核酸分子(DNA或RNA)的檢測和/或分析設計的測試。公司還利用自有技術爲其Co-Dx PCR在家和點-of-care平台設計特定測試,並尋找用於除傳染性疾病以外應用的遺傳標記。

SOURCE Co-Diagnostics

資料來源:Co-Diagnostics

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新聞在PRNEWSWIRE.COM上特色呈現嗎?

440k+
440k+

Newsrooms &
新聞發佈室&

Influencers
影響力人士
9k+
9k+

Digital Media
數字媒體

Outlets
Outlets
270k+
270k+

Journalists
新聞記者

Opted In
Opted In
GET STARTED
開始使用

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論